Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Cancer Vaccines/immunology"'
Autor:
Daniel J. Powell, Lana E. Kandalaft, Renee Frank, Thomas Garrabrant, Priyanka Duttagupta, Hongzhe Li, Denarda Dangaj, Davide Bedognetti, Ian S. Hagemann, George Coukos, Emese Zsiros, Ena Wang, Michael Feldman, Janos L. Tanyi, Francesco M. Marincola, Carl H. June, Lin Zhang, Bruce L. Levine
Publikováno v:
Clinical Cancer Research, vol. 21, no. 12, pp. 2840-2850
Purpose: Chemokines are implicated in T-cell trafficking. We mapped the chemokine landscape in advanced stage ovarian cancer and characterized the expression of cognate receptors in autologous dendritic cell (DC)–vaccine primed T cells in the conte
Publikováno v:
Frontiers in immunology, vol. 9, pp. 2076
Tissue resident memory T cells (Trm) are a subset of memory T cells mainly described in inflammation and infection settings. Their location in peripheral tissues, such as lungs, gut, or skin, makes them the earliest T cell population to respond upon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::8c82ee6b1fd1f5e256add27abb8b1986
https://serval.unil.ch/resource/serval:BIB_A1AD953828BB.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_A1AD953828BB.P001/REF.pdf
Publikováno v:
Journal of translational medicine, vol. 15, no. 1, pp. 142
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Journal of Translational Medicine
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Journal of Translational Medicine
Background Immunotherapy consists of activating the patient’s immune system to fight cancer and has the great potential of preventing future relapses thanks to immunological memory. A great variety of strategies have emerged to harness the immune s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6866e76561312216063440f5505aa3
https://serval.unil.ch/resource/serval:BIB_860F405AA782.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_860F405AA782.P001/REF.pdf
Autor:
Matthias Kreuzaler, Min Lu, Stephanie Darbre, Alfred Zippelius, Daniel D. Pinschewer, Mario Kreutzfeldt, Philipp Müller, Nicolas Page, Weldy V. Bonilla, Stéphanie Favre, Sandra M. Kallert, Max Löhning, Sanjiv A. Luther, Doron Merkler, Florian Kreppel
Publikováno v:
Nature Communications, Vol. 8 (2017) P. 15327
Nature Communications
Nature communications, vol. 8, pp. 15327
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
Nature Communications
Nature communications, vol. 8, pp. 15327
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
Viral infections lead to alarmin release and elicit potent cytotoxic effector T lymphocyte (CTLeff) responses. Conversely, the induction of protective tumour-specific CTLeff and their recruitment into the tumour remain challenging tasks. Here we show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84cecd39857413817068e6b7d5865400
https://archive-ouverte.unige.ch/unige:98397
https://archive-ouverte.unige.ch/unige:98397
Autor:
Daniel E. Speiser, Emanuela M. Iancu, Hélène Maby-El Hajjami, Laurène Cagnon, Petra Baumgaertner, Philippe O. Gannon, Samia Abed Maillard, Nathalie Rufer, Alexandre Huber
Publikováno v:
Clinical cancer research, vol. 23, no. 13, pp. 3285-3296
Purpose: Patients with cancer benefit increasingly from T-cell-based therapies, such as adoptive T-cell transfer, checkpoint blockade, or vaccination. We have previously shown that serial vaccinations with Melan-A MART-1 26-35 peptide, CpG-B, and inc
Autor:
Philippe Guillaume, Nathalie Rufer, Petra Baumgaertner, Daniel E. Speiser, Tanja Lövgren, Sébastien Wieckowski, Estelle Devevre, Immanuel F. Luescher
Publikováno v:
Cancer immunology immunotherapy : CII
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2012, 61 (6), pp.817-826. ⟨10.1007/s00262-011-1140-1⟩
Cancer Immunology, Immunotherapy, vol. 61, no. 6, pp. 817-826
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2012, 61 (6), pp.817-826. ⟨10.1007/s00262-011-1140-1⟩
Cancer Immunology, Immunotherapy, vol. 61, no. 6, pp. 817-826
International audience; In mice, vaccination with high peptide doses generates higher frequencies of specific CD8+ T cells, but with lower avidity compared to vaccination with lower peptide doses. To investigate the impact of peptide dose on CD8+ T c
Autor:
Daniel E. Speiser, Leticia Barba, Amandine Legat, Lukas Baitsch, Nathalie Rufer, Hanifa Bouzourene, Sunil K. Raghav, Petra Baumgaertner, Pedro Romero, Bart Deplancke, Sébastien Wieckowski, Estelle Devevre
Publikováno v:
Journal of Clinical Investigation, vol. 121, no. 6, pp. 2350-2360
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2011, 121 (6), pp.2350-2360. ⟨10.1172/JCI46102⟩
The Journal of clinical investigation
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2011, 121 (6), pp.2350-2360. ⟨10.1172/JCI46102⟩
The Journal of clinical investigation
International audience; In chronic viral infections, CD8⁺ T cells become functionally deficient and display multiple molecular alterations. In contrast, only little is known of self- and tumor-specific CD8⁺ T cells from mice and humans. Here we d
Autor:
Emanuela M. Iancu, Petra Baumgaertner, Pedro Romero, Lukas Baitsch, Sébastien Wieckowski, Nathalie Rufer, Bhawna Gupta, Daniel E. Speiser, Olivier Michielin
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15318-15323
Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15318-15323
Immune protection from infectious diseases and cancer is mediated by individual T cells of different clonal origin. Their functions are tightly regulated but not yet fully characterized. Understanding the contribution of each T cell will improve the
Autor:
Stefan Herz, Daniel Tuse, J.-E. Butler-Ransohoff, Alison A. McCormick, Susana Inogés, Victor Klimyuk, Maurizio Bendandi, Romy Kandzia, Sylvestre Marillonnet, J. Lenz, Guy Vancanneyt, A. Nickstadt, Frank Thieme, R. Fröde, Yuri Gleba, A. Lopez-Diaz de Cerio, Helena Villanueva, Elena Soria
Publikováno v:
Annals of Oncology. 21:2420-2427
BACKGROUND: Animal and clinical studies with plant-produced single-chain variable fragment lymphoma vaccines have demonstrated specific immunogenicity and safety. However, the expression levels of such fragments were highly variable and required comp
Autor:
Davide Soldini, Lotta von Boehmer, Alexander Knuth, Natko Nuber, Holger Moch, Claudia Matter, Jean-Marie Tiercy, Reinhard Dummer, Alessandra Curioni-Fontecedro, Maries van den Broek
Publikováno v:
Proceedings of the National Academy of Sciences, Vol. 107, No 34 (2010) pp. 15187-15192
Cancer/testis (CT) antigens represent prime candidates for immunotherapy in cancer patients, because their expression is restricted to cancer cells and germ cells of the testis. MAGE-C1/CT7 is a CT antigen that is highly expressed in several types of